Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (141)

Latest Posts

About This Stock More About This Stock
Healthcare Investing Ideas Big And Small
Article By: Marc Lichtenfeld
Monday, January 15, 2018 9:00 PM EST
With a dire need for growth, many in the industry expect the larger biotech and pharmaceutical companies to open their wallets and acquire smaller companies with novel drugs in development.
In this article: BMY, GSK, JNJ, PFE, AVXL, IMMP, BMRN, FOLD, SGEN, MBOT
Read
Johnson & Johnson Downgraded To Neutral From Overweight At JPMorgan
Article By: The Fly
Tuesday, January 2, 2018 8:03 AM EST
JPMorgan analyst Michael Weinstein downgraded Johnson & Johnson to Neutral with an unchanged price target of $150.
In this article: JNJ Also: ABT, BAX
Read
4 Large-Cap Pharma Stocks That Outperformed The S&P This Year
Article By: Zacks Investment Research
Sunday, December 31, 2017 2:53 PM EST
Upbeat quarterly results, rise in demand on new product sales, successful innovation and product line expansion, strong clinical study results as well as strong performance of legacy products propelled the large-cap drug sector to new highs in 2017.
In this article: AZN, JNJ, NVO, ABBV Also: RHHBY
Read
Biotech Year One: A Year Of Trials Tribulations And Discovery
Article By: Kieran O'Dea
Monday, December 25, 2017 8:24 AM EST
The biotech market is its own beast, derived from the aggregate opinions and knowledge of the mainstream thought. The market has a binary, linear, and simplistic approach to trial results ignoring the context in which each trial is conducted.
In this article: IBB, XBI, XPH, SPY, TEVA, AGN, JNJ, MYL, BMY, BIIB, PFE, MRK, INCY
Read
Why The Dividend Aristocrats Are Good Investments To Generate Long-Term Wealth
Article By: SureDividend
Saturday, December 16, 2017 4:15 PM EST
For most, the destination of investing is financial independence. The stock market is an excellent vehicle to accomplish this. More specifically, dividend growth stocks have generated strong returns over the past several decades.
In this article: JNJ, KO, PG
Read

PARTNER HEADLINES

Latest Tweets for $JNJ

No tweets yet!